PLAU antibody (AA 396-426)
Quick Overview for PLAU antibody (AA 396-426) (ABIN3032244)
Target
See all PLAU AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- AA 396-426
-
Purpose
- UPA Antibody
-
Purification
- Purified
-
Immunogen
- A portion of amino acids 396-426 from the human protein was used as the immunogen for this UPA antibody.
-
Isotype
- Ig Fraction
-
-
-
-
Application Notes
- Titration of the UPA antibody may be required due to differences in protocols and secondary/substrate sensitivity.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- In 1X PBS, pH 7.4, with 0.09 % sodium azide
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- -20 °C
-
Storage Comment
- Aliquot the UPA antibody and store frozen at -20oC or colder. Avoid repeated freeze-thaw cycles.
-
-
- PLAU (Plasminogen Activator, Urokinase (PLAU))
-
Alternative Name
- UPA
-
Background
- PLAU, a member of the peptidase family S1, is a potent plasminogen activator and is clinically used for therapy of thrombolytic disorders. PLAU specifically cleaves the Arg-|-Val bond in plasminogen to form plasmin. The protein is found in high and low molecular mass forms. Each consists of two chains, A and B. The high molecular mass form contains a long chain A. Cleavage occurs after residue 155 in the low molecular mass form to yield a short A1 chain. The protein is used in Pulmonary Embolism (PE) to initiates fibrinolysis. Structurally, PLAU contains 1 EGF-like domain and 1 kringle domain.
-
UniProt
- P00749
-
Pathways
- Cellular Response to Molecule of Bacterial Origin, Carbohydrate Homeostasis, Autophagy, Smooth Muscle Cell Migration
Target
-